Monday July 16, 2018
Home India An Initiative...

An Initiative towards Ruling out Child Labour in Andhra Pradesh by several Government departments and NGOs

The sole intention of the committee is to induct children into education institutions, execute raids and educate the people.

0
//
227
Child Labour, VOA
Republish
Reprint
  • The kingpin intention of the committee is to induct children into education institutions, execute raids and educate the people
  • The drive will be conducted from June 12 to 18
  • Child labor can be eradicated through proper enrolment of children in schools, identify dropouts and admit them in schools

Andhra Pradesh, June 1, 2017: A committee has been constituted by the officials of various government departments and NGOs with the motive of driving against the child labor in Krishna district, Andhra Pradesh. This drive will be conducted from June 12 to 18.

The kingpin intention of the committee is to induct children into education institutions, execute raids and educate the people. This would be achieved through proper enrolment of children in schools, identify dropouts and admit them in schools, conduct raids in different establishments and houses to prevent child labour and explain the people child rights and welfare, mentioned The Hindu.

Look for latest news from India in NewsGram.

The committee comprises of government officials from departments like National Child Labour Project (NCLP), Women Development and Child Welfare, Juvenile Welfare, South Central Railway and Vijayawada Municipal Corporation.

Sarva Siksha Abhiyaan, Rajiv Vidya Mission, Education and other departments and representatives of Childline have also joined hands with these departments. Apart from these, Nava Jeevan Bala Bhavan, SKCV, CRAF, Care and Share, BIRDS, Arunodaya, Prajwala and Annamma Society are also the members.

“As part of the Anti-Child Labour Day, awareness programs on child rights, seminars, workshops, special drives and rallies will be conducted during the week-day programme,” NCLP Project Director Anjaneya Reddy said.

– prepared by Himanshi Goyal of Newsgram, Twitter: @himanshi1104

 

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)